Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT02701114 |
Date of registration:
|
29/02/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Proximal Versus Distal Adductor Canal Blocks for Total Knee Arthroplasty
|
Scientific title:
|
A Comparison of Proximal Versus Distal Continuous Adductor Canal Blocks After Total Knee Arthroplasty |
Date of first enrolment:
|
February 2016 |
Target sample size:
|
76 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02701114 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Neil A Hanson, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Virginia Mason Medical Center |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Unilateral Total Knee Arthroplasty
- ASA physical status I-III
- >18 years old
- Non-pregnant
- Consent to participate in the study
Exclusion Criteria:
- Refusal to participate
- <18 years old
- Chronic opioid use
- Localized infection Pregnancy Pre-existing coagulopathy Allergy to ultrasound gel or
local anesthetics Contraindication to or refusal of spinal anesthetic
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Post-Operative Pain
|
Intervention(s)
|
Procedure: Distal Adductor Canal Block
|
Procedure: Proximal Adductor Canal Block
|
Primary Outcome(s)
|
Opioid Consumption (IV Morphine Equivalents)
[Time Frame: 24 Hours]
|
Secondary Outcome(s)
|
Pain (Numeric Rating)
[Time Frame: 48 Hours]
|
Quadriceps Strength (% of Baseline)
[Time Frame: 48 Hours]
|
Distance Ambulated (Feet)
[Time Frame: 48 Hours]
|
Opioid Consumption (IV Morphine Equivalents)
[Time Frame: 48 Hours]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|